Investing.com - Hologic (NASDAQ:HOLX) reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Hologic announced earnings per share of $0.82 on revenue of $4B. Analysts polled by Investing.com anticipated EPS of $0.38 on revenue of $614.73M.
Hologic shares are up 22% from the beginning of the year , still down 0.28% from its 52 week high of $64.19 set on July 29. They are outperforming the S&P 500 which is up 0.86% from the start of the year.
Hologic shares gained 7.80% in after-hours trade following the report.
Hologic follows other major Healthcare sector earnings this month
Hologic's report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Roche Holding ADR had beat expectations on July 23 with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar